Overdose deaths from fentanyl and other opioids have surged but medications that could save thousands of lives "are sitting on the shelf unused," according to new research.
Indivior was accused of using illegal strategies to keep generic versions of the opioid-treatment medication Suboxone off the market. The company denies wrongdoing.
Federal restrictions seemed to explain why many doctors weren't prescribing medication for opioid addiction. But some caution that removing those rules isn't enough to overcome hesitancy and stigma.
ER doctors wanted to hospitalize the young man to help ease his withdrawal from opioid dependence. But he declined because he couldn't afford it. His mom says no one told him he had financial options.
The federal government has waived a law that required an in-person doctor's visit before patients could be prescribed drugs that quell withdrawal symptoms. That's a boon for patients, counselors say.
Doctors and nurses are often barred from turning to FDA-approved medications that research shows to be the most effective way to quit. Critics of that policy say stigma is undermining best practice
The deal to resolve all U.S. federal investigations and claims is the biggest drug industry settlement so far stemming from the nation's deadly opioid epidemic.
"Just continually putting people in jail, that's not doing anything for them," says an Everett, Wash. police officer who connected with one drug user, Shannon McCarty, and helped her get off drugs.
British drug maker Indivior faces felony charges after allegedly trying to falsely convince doctors that its opioid products were safer than cheaper generic alternatives.
Evidence shows the drugs methadone and buprenorphine can help people recover from opioid use disorder by reducing withdrawal symptoms and cravings. So why do many sobriety facilities ban their use?